Results
|
44481.
|
|
|
44482.
|
|
|
44483.
|
|
|
44484.
|
|
|
44485.
|
|
|
44486.
|
Novel Phase I dose de-escalation design trial to determine the biological modulatory dose of the antiangiogenic agent SU5416. [electronic resource] by
- Dowlati, Afshin
- Robertson, Kelly
- Radivoyevitch, Tomas
- Waas, John
- Ziats, Nicholas P
- Hartman, Paul
- Abdul-Karim, Fadi W
- Wasman, Jay K
- Jesberger, Jack
- Lewin, Jonathan
- McCrae, Keith
- Ivy, Percy
- Remick, Scot C
Producer: 20060404
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 11
Availability: No items available.
|
|
44487.
|
|
|
44488.
|
|
|
44489.
|
|
|
44490.
|
|
|
44491.
|
|
|
44492.
|
|
|
44493.
|
|
|
44494.
|
|
|
44495.
|
|
|
44496.
|
|
|
44497.
|
|
|
44498.
|
|
|
44499.
|
|
|
44500.
|
|